Oral Anti-Cancer Drug (OACD) Fees


OACDs meet the requirements for coverage under the Omnibus Budget Reconciliation Act of 1993 (OBRA '93) and are billed using the National Drug Code (NDC) when submitted to the Durable Medical Equipment Medicare Administrative Contractors (DME MAC). Fees for OACDs are subject to change on a quarterly basis. 

The creation and maintenance of Quarterly OACD fee files by the PDAC has been discontinued due to claims payment system modernization and enhancement efforts. To identify applicable fees for OACDs please reference the appropriate Average Sales Price (ASP) pricing files on CMS’s website for the specific drug information and fees.

View archived OACD Update files
Year Quarter
2026 Quarter 3 - Updated June 24, 2026
Quarter 2 - Updated March 24, 2026
Quarter 1 - Updated December 23, 2025
2025

Quarter 4 - Updated September 23, 2025
Quarter 3 - Updated June 26, 2025
Quarter 2 - Updated March 31, 2025
Quarter 1 - Updated December 23, 2024

2024

Quarter 4  - Updated September 25, 2024
Quarter 3 - Updated June 21, 2024
Quarter 2 - Updated March 22, 2024
Quarter 1 - Updated December 21, 2023

2023

Quarter 4 - Updated September 21, 2023
Quarter 3 - Updated June 21, 2023
Quarter 2 - Updated March 31, 2023
Quarter 1 - Updated December 22, 2022

2022

Quarter 4 - Updated September 27, 2022
Quarter 3 - Updated June 20, 2022
Quarter 2 - Updated March 23, 2022
Quarter 1 - Updated December 21, 2021

2021

Quarter 4 - Updated September 20, 2021
Quarter 3 - Updated June 21, 2021
Quarter 2 - Updated March 23, 2022
Quarter 1 - Updated December 22, 2020



Oral Anti-Cancer Drug (OACD) Fees Articles